Startpagina>Klinisch wetenschappelijk onderzoek>Klinische studies>AUDIOWOLF

How to use the speech recognition tool?

2020-004594-43

AUDIOWOLF

A phase II, open-label, efficacy study of daily administration of sodium valproate in patients clinically affected by Wolfram syndrome due to monogenic mutation.

Type: Interventional



Status of the trial: Active, Recruiting

Orphan Drug Recognition: No

Inclusion

  • Opening Date: 2019-03-26
  • Closing Date: 2021-08-31

Criteria

More information

Children: Yes

Adults: Yes

Funder Type: public

HCP: Principal investigators

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Neuro-Ophthalmology Rare Diseases (WG2)

Subscribe to our mailing list

* indicates required

This ERN is supported by: